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Disruption of POF1B Binding to Nonmuscle Actin Filaments Is
Associated with Premature Ovarian Failure
Arnaud Lacombe,* Hane Lee,* Laila Zahed, Mahmoud Choucair, Jean-Marc Muller,
Stanley F. Nelson, Wael Salameh, and Eric Vilain
Premature ovarian failure (POF) is characterized by elevated gonadotropins and amenorrhea in women aged !40 years.
In a Lebanese family with five sisters who received the diagnosis of POF, we established linkage to the long arm of the
X chromosome (between Xq21.1 and Xq21.3.3), using whole-genome SNP typing and homozygosity-by-descentmapping.
By sequencing one candidate gene within that region, POF1B, we identified a point mutation localized in exon 10. This
substitution of a nucleotide (GrA), at position 1123, results in an argininerglutamine mutation of the protein sequence
at position 329 (mutation R329Q). All the affected family members were homozygous for the mutation, whereas the
unaffected members were heterozygous. Because POF1B shares high homology with the tail portion of the human myosin,
we assessed the ability of both wild-type and mutant POF1B proteins to bind nonmuscle actin filaments in vitro. We
found that the capacity of the mutant protein to bind nonmuscle actin filaments was diminished fourfold compared
with the wild type, suggesting a function of POF1B in germ-cell division. Our study suggests that a homozygous point
mutation in POF1B influences the pathogenesis of POF by altering POF1B binding to nonmuscle actin filaments.
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A number of physiological changes are associated with
menopause: decline in the number of ovarian follicles,
menstrual irregularities, ovarian hormonal deficiency, an-
ovulation, decreased fertility, and, finally, a complete and
irreversible cessation of menses.1,2 In Western populations,
it has been estimated that this phenomenon occurs at a
mean age of 50 years. However, in 2%–3% of women,
cessation of menses occurs before age 40 years.3,4 This con-
dition, called “premature ovarian failure” (POF),5 is char-
acterized by primary or secondary amenorrhea, hypoes-
trogenism, and elevated serum-gonadotropin levels.
The etiology of POF is poorly understood because its
known causes are highly heterogeneous. POF is most com-
monly caused by the presence of autoantibodies,6 but the
disorder can also have genetic origins.7,8 Although the X
chromosome undergoes inactivation in somatic tissues, it
is reactivated in oogonia, and both alleles of the X-chro-
mosome genes involved in ovarian morphogenesis are
required for normal ovarian development. As a result, X
monosomy or X rearrangements disrupting genes of the
X chromosomes are sufficient to cause ovarian failure. Au-
tosomal mutations in the follicle-stimulating hormone
(FSH) and in both FSH and luteinizing-hormone (LH) re-
ceptor genes have already been reported.9
It has often been observed that abnormalities in the X
chromosome are present in women affected by POF. A
“critical region” for normal ovarian function has been re-
ported on the long arm of the X chromosome that spans
Xq13.3-q26/27.10 Within this region, according to break-
point mapping of X-autosome translocations, two regions
called “POF1” and “POF2” have been identified. The num-
ber of genes involved in POF is small and localized to
either POF1 or POF2. POF1 extends from Xq21-qter and
is home to XPNPEP2 on Xq2511 and the FMR1 gene. POF2
extends from Xq13.3 to Xq21.1 and harbors DACH2 in
Xq21.3,12 DIAPH2 in proximal Xq22,13 and POF1B, the
gene that is the subject of the present study. Individuals
with the FMR1 premutation have idiopathic POF.
POF1B is thus located within the critical region for nor-
mal ovarian function, is known to escape X inactivation,
and was identified as a candidate gene for POF in a patient
with a breakpoint in the third intron because of an X;1
translocation.14,15 The function of the POF1B protein re-
mains unknown, and there is no genetic evidence of its
role in POF. A mutation analysis of POF1B performed in
an Italian population showed that a number of heterozy-
gous sequence variants were present in both patients with
POF and healthy controls. It was concluded that the POF1B
gene was not associated with POF.16
In the present study, we describe a Lebanese familial case
of POF, with linkage to Xq21. We identify a point muta-
tion in the candidate gene POF1B and demonstrate that
this mutation disrupts the normal binding of POF1B to
nonmuscle actin filaments.
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Material and Methods
Pedigree
We report a familial Lebanese case of POF wherein the proband’s
parents, who are consanguineous, had five affected daughters,
one healthy son, four other sons (two with albinism and blind-
ness due to retinitis pigmentosa, one with familial Mediterranean
fever/Behcet disease [FMF/Behcet], and one who died at age 14
years), and one healthy daughter (fig. 1A). The fertile, unaffected
daughter is also in a consanguineous marriage and has several
affected children with blindness due to retinitis pigmentosa and/
or with FMF/Behcet. We had access to the DNA of the healthy
son, all the daughters, and the mother but not the father of all
the affected daughters, who was deceased, and the three sons
with albinism/blindness or FMF/Behcet, who declined to be inter-
viewed for the study. All three of these individuals were married
and had progeny, but we have little clinical information available
beyond what was given from participating family members.
POF Diagnosis
The proband (individual 41) was aged 31 years at presentation.
She is single, has never been pregnant, and had a history of de-
layed puberty with primary amenorrhea. She denied any history
of galactorrhea, anosmia, or headaches. She continued to increase
in height until she began sex-hormone treatment. Relevant as-
pects of her physical exam showed a height of 181 cm and weight
of 81 kg, normal axillary hair, and breasts of Tanner stage 3. She
also has documented osteoporosis and “weak teeth.” She had five
sisters who were aged 45, 41, 39, 34, and 29 years at the time of
her diagnosis. The eldest was married to a first cousin with whom
she had children; among her children are two daughters who are
both blind due to retinitis pigmentosa and who have normal
menses, LH, and FSH. The latter four sisters also have primary
amenorrhea; in at least one sister, osteoporosis and dental prob-
lems similar to those of the proband are documented. One of the
proband’s albino brothers also married his first cousin and has a
daughter who is infertile, but no further clinical information on
her was available. The second albino brother married an unrelated
partner and has two daughters who have normal menses. The
proband was treated with Premarin and Provera, which resulted
in resumption of her menses and advancement of her breasts and
pubic hair to Tanner stage 5 after 2 years of therapy. Her electro-
lytes were within normal limits. Before treatment with sex hor-
mones, her LH was 11.5 IU/liter, FSH was 56.7 IU/liter, E2 was
8.9 IU/liter, and testosterone was 39 IU/liter. Her karyotype was
46,XX. Adrenocorticotropic hormone (ACTH)-stimulation test
showed dehydroepiandrosterone sulfate of 2,009 IU/liter and
17OH-P of 0.35 at baseline, which went to 2,363 and 3.15, re-
spectively, 60 min after ACTH stimulation.
Linkage
After obtaining informed consent from all study individuals, blood
samples were collected and genomic DNA was extracted by stan-
dard salt-precipitation technique.17 The research protocol was ap-
proved by the local institutional review board. Linkage was tested
using a homozygosity-by-descent mapping approach, with data
derived from the GeneChip Mapping 10K array (Affymetrix). To
test for linkage, SNP calls generated by GeneChip DNA Analysis
Software were converted to different formats by scripts written
in the lab for each program used (available from H.L. on request).
Mendelian and non-Mendelian errors were detected with Merlin
(Multipoint Engine for Rapid Likelihood Interference) and MINX
(Merlin for X chromosome). MAPMAKER/HOMOZ version 0.9 was
used to perform homozygosity-mapping analysis of 11,149 SNPs
from the 10K mapping array. Multipoint LOD score was calcu-
lated with MAPMAKER/HOMOZ for the region flanking the au-
tozygous segment of interest. Because of the program constraints,
the genome scan was run using a 50-marker window. Asian allele
frequencies provided by Affymetrix were used for the analysis.
Haplotypes were constructed with Merlin, and a list of candidate
genes was generated using University of California–Santa Cruz
(UCSC) resources from the genomic region identified by the link-
age result. There are 270 known genes in this region.
Sequencing
From the list of candidate genes, we performed a mutation screen-
ing of diaphanous (MIM 300108) and POF1B (MIM 311360), two
genes known to be interrupted by a breakpoint in patients af-
fected by POF. Primers were designed for each exon and then
were amplified by PCR. PCR product was sequenced by an auto-
mated DNA sequence analyzer (ABI Prism Tm 373 [Perkin-Elmer]).
Finally, the sequences were analyzed and screened for mutation.
Incidence of the R329Q Variant in the Lebanese Population
Presence of the R329Q variant was investigated in 92 women from
the same ethnic background as our family. Individuals were known
to be fertile and had a normal obstetric history; therefore, they
were appropriate controls for our study. The DNA was collected
in an anonymous way, with complete deidentification. Mutation
screening in exon 10 of each control was performed using a di-
deoxy sequencing method (Agencourt Bioscience).
Protein Domain Prediction
To assess POF1B protein function, the protein sequence was sub-
mitted to different database sources: National Center for Bio-
technology Information (NCBI) protein alignment, NCBI protein
domain prediction, and Predict Protein software.
Plasmids
POF1B cDNA was purchased from OriGene. To produce the cDNA
mutant in vitro, we used the QuikChange Site-Directed Muta-
genesis Kit (Stratagene) and followed the manufacturer’s instruc-
tions. The mutated oligonucleotide primers were designed as fol-
lows: forward, 5′-GCTAAATGTGGACAGCACTAGTTGGAGTGA-
CTTATCAG-3′; reverse, 5′-CTGATAAGTCACTCCAACTAGTGCT-
GTCCACATTTAGC-3′. Sequences and presence of the point mu-
tation were checked by automated DNA sequencing (ABI Prism
TSm 373 [Perkin-Elmer]).
In Vitro Protein Production
Both wild-type and mutant cDNA were used as a template to
produce proteins in vitro, with use of a transcription translation
kit (TNT Quick Coupled Transcription/Translation kit [Promega]).
Yields of protein were estimated from the incorporation of 35S-
methionine in reactions that were performed in parallel with non-
radiolabeled syntheses. The 35S-radiolabeled wild-type and mu-
tant POF1B proteins were run on a 12% SDS-PAGE gel. The gel
was dried, exposed, and developed using a phosphorimager
cassette.
Figure 1. Pedigree and linkage. A, Pedigree. B, Haplotype structure of the pedigree. Homozygous blocks on the X chromosome that
are shared by all five affected daughters are shown as blackened bars. Each marker is labeled with its name, and the genetic distance
appears to the right; blackened symbols indicate affected individuals. Fifty SNPs in the middle of each block were omitted because of
the space constraint. Note that all affected daughters share identical haplotypes over a 21-Mb homozygous interval that the healthy
daughter does not share. C, Genomewide-scan linkage analysis under an assumption of recessive inheritance and first-cousin consan-
guineous mating. Multipoint LOD scores are plotted along the Y-axis, and chromosomal position is plotted along the X-axis. Chromosomes
are listed in numerical order across the top.
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Figure 2. Representative sequence chromatogram of exon 10 of
the POF1B gene after sequencing of the members of the family.
A, Sequence analysis of the mother’s and unaffected daughter’s
DNA. At np 1132, those members carry either a cytosine (C) or a
thymine (T), which shows they are heterozygous. B, Sequence an-
alysis of an affected daughter’s DNA. At the same np 1132, all
patients carry a T and are homozygous for the mutation. C, Se-
quence analysis of DNA of an unrelated female control. The control
individual is a homozygote and carries a C.
Actin-Myosin Binding Study
The ability of both wild-type and mutant POF1B protein to bind
nonmuscle actin filaments in vitro was assessed using a non-
muscle actin kit purchased from Cytoskeleton. A constant and
equal quantity of wild-type and mutant stock protein were in-
cubated with nonmuscle actin at room temperature for 30 min.
Each experiment was run in duplicate and also with a control in
which actin was substituted by an identical volume of actin buffer.
Ultracentrifugation was performed at for 1.5 h at 4C.150,000 g
Both supernatants and pellets were run on a 4%–20% (w/v) SDS-




A panel of 110,000 SNPs was typed on all individuals with
use of the 10K-SNP mapping assay (Affymetrix). The data
from this microarray-based approach resulted in high in-
formation content throughout the genome. The mean call
rate (SD) was (with a range of 89.6%–94% 0.03%
96.63%). The distribution of genotype calls was consistent
over AA, AB, and BB calls, showing slightly lower AB calls
in most of the samples, as is expected for an inbred family.
Mendelian error rate and non-Mendelian error rate were
0.08% and 0.16%, respectively. Genotypes for SNPs with
at least one error were changed to “No Call” across all the
family members before starting the analysis. Since there
was no information on the genetic relationship between
the parents of the affected women, we counted the pos-
sible autozygous segments in the autosomal chromosomes
of the descendants, to determine whether it was likely that
the affected daughters were from a consanguineous mat-
ing, which would permit us to use homozygosity by de-
scent to map the disease interval.18 Identification of the
autozygous segments by counting the long homozygous
segments was possible because of the high-density SNPs
with mean genetic map distance of 0.32 cM and mean
heterozygosity of 0.37 cM. Since regions of autozygosity
are expected to be large with first- or second-cousin in-
breeding,18 we counted the number of segments with a min-
imum of 10 consecutive homozygous SNPs that spanned
at least 10 cM in all autosomes. The estimated number of
autozygous blocks 110 cM is 6–10 for first-cousin mating,
3–5 for first-cousin-once-removed mating, and 1–3 for
second-cousin mating. The six siblings in our study have
an average (SD) of homozygous blocks, which7 2.7
strongly suggests that they are descendents of a consan-
guineous marriage of recent relatives (first-cousin-once-
removed marriage or first-cousin marriage).
We searched through the genome and detected a single
long segment of homozygosity on the X chromosome that
was shared only by the affected daughters (fig. 1B). The
unaffected daughter was heterozygous for that region. Hap-
lotypes were constructed with Merlin, and the homozy-
gous segment spanned bases 41926093–92958387 (UCSC
May 2004 assembly). To rule out the possibility that there
could be shared autozygous segments on the autosomal
chromosomes, we scanned the remaining genome with
MAPMAKER/HOMOZ for homozygosity-mapping analy-
sis. Assuming the parents are first cousins, we performed
analysis under an autosomal recessive inheritance model.
Throughout the autosomal chromosomes, there was no
homozygous stretch shared by only the affected daugh-
ters and not by the unaffected daughter. The locus of link-
age was localized to the long arm of the X chromosome
(genomic region between Xq21.1 and Xq 21.3.3), corre-
sponding to a 21-Mb region (fig. 1C). Because of the long
length, this interval is likely autozygous in all of the af-
fected daughters. On the basis of the physical interval, a
list of 270 known genes was generated, and two candidate
genes (POF1B and diaphanous) were analyzed.
Family Members with POF Who Carry a Point Mutation
in Exon 10 of POF1B
To identify a possible involvement for one of the candi-
dates in POF, we screened each exon by direct sequencing
of two candidates that have been demonstrated to be dis-
rupted by a breakpoint (localized in introns) in patients
affected by POF: diaphanous and POF1B.
Sequencing of diaphanous exons failed to reveal a mu-
tation for any of the family members (data not shown).
However, when screening POF1B, we identified a point
mutation in exon 10, a GrA substitution at np 1132 (fig.
2). This variant results in an amino acid change of argi-
ninerglutamine at position 329 (R329Q) in the protein
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Figure 3. Nonmuscle actin–binding assay of wild-type (WT) and
mutant POF1B. A, A constant and equal concentration of 35S-ra-
diolabeled wild-type and mutant POF1B was incubated with 12 mM
nonmuscle actin and was spun down at for 1.5 h at150,000 g
4C. As a control, the same concentrations of 35S-radiolabeled pro-
teins were incubated under the same conditions, but nonmuscle
actin was replaced with the same volume of actin buffer. The top
panel represents SDS-PAGE gel picture after 70-h exposure from su-
pernatant of each sample run in duplicate (Supernatant), whereas
the bottom panel corresponds to SDS-PAGE gel picture from pellets
(Pellet) after the same time of exposure. Lanes correspond to wild-
type POF1B (1 and 2) or mutant POF1B (3 and 4), in the presence
(2 and 4) or absence (1 and 3) of nonmuscle actin filaments.
Results are representative of three independent experiments. B,
SDS-PAGE analysis of in vitro–translated proteins. The same amount
of in vitro–translated protein reaction of wild-type and mutant
POF1B was run on an SDS-PAGE gel, to measure the yield of pro-
duced proteins. C, Quantification of the radioactive signal in the
pellet after the nonmuscle actin–binding assay. A triple asterisk
(***) indicates .P ! .005
sequence. The unaffected women screened in the family
(one daughter and the mother) are both heterozygous at
this position, whereas all five affected daughters are homo-
zygous for the mutation. Since the father died before the
time of investigation, we were unable to screen his DNA.
It is conceivable that the variant detected is a common
SNP. To measure the incidence of the R329Q variant in
the general Lebanese population, we tested whether the
nucleotide variant is present in 92 individuals from a sim-
ilar ethnic background. Although none carried the muta-
tion in a homozygous state, results of sequence screening
(data not shown) revealed that the mutation was present,
in a heterozygous state, in 4 of the 92 control women.
Thus, the estimated allele frequency in Lebanon is 2.2%.
The predicted rate of homozygosity in this population
would be 0.048% and could account for a fraction of the
POF detected in this population.
POF1B Protein Shares a High Degree of Homology
with Human Myosin
Although POF1B was identified as a candidate for POF,15
little is known about its expression and potential role. To
begin investigation of its function, we performed protein-
sequence comparisons against different databases. Results
from NCBI protein alignment indicate that the protein
shares 42% similarity and 17% identity with the human
perinatal myosin, also named “heavy polypeptide 8.”
This identity localizes to the C terminus and is, in fact,
a myosin tail. No similarity with other proteins was found
for sequence at the N-terminus.
A “predict protein” search indicated that the variantalters
the arginine with an amino acid triplet, serine-leucine-
arginine, which is part of a protein kinase C (PKC) phos-
phorylation-recognition site. Thus, this rare variant may
have functional consequences.
Mutant POF1B Binds Nonmuscle Actin with Less Affinity
Than Wild-Type POF1B In Vitro
Previous studies have shown that, during ovarian devel-
opment, the alteration of the final stock of oocytes could
lead to POF. Given these findings and the similarity of the
C terminus of POF1B to the myosin tail of the human
myosin, we next tested the hypothesis that POF1B could
interact with actin filaments and therefore have a possible
role in the cell-division process. To do so, we assessed the
ability of both the wild-type and mutant proteins to as-
semble with nonmuscle actin in vitro (fig. 3). We show
that, in the supernatant fraction, which mainly contains
protein not bound to actin, the decrease of intensity of
the signal after actin binding in wild-type POF1B is larger
than in R329Q mutant (fig. 3A). Conversely, in the pellet,
in the presence of actin, the signal was more intense in
the wild type than in R329Q mutant (fig. 3A). After quan-
tification of three independent experiments (each in du-
plicate), we recorded an average 48% binding to actin fil-
ament with the wild-type POF1B, whereas it was 12% with
the R329Q variant ( ) (fig. 3C). There was no dif-Pp .0024
ference in the yield of protein produced after the in vitro
translation (fig. 3B).
Discussion
The molecular mechanisms that lead to POF are poorly
understood. Most frequently, POF cases are idiopathic or
sporadic.3 Previous studies have described familial cases of
POF with a dominant mutation or an association with X-
chromosome abnormalities.19,20 A major obstacle to the
identification of new genes responsible for POF is the lack
of familial cases with full pedigrees.21 In the present study,
we show that a homozygous point mutation in POF1B, a
gene mapping to the distal end of the POF2 critical in-
terval on X chromosome, may be linked to the pathogen-
esis of POF. We show that each affected 46,XX daughter
in a Lebanese family carries a homozygous R329Q variant
in exon 10 of POF1B at np 1132, whereas unaffected fe-
males (one healthy daughter and the mother) are hetero-
zygous for this variant. This variant alters the binding of
the POF1B protein to nonmuscle actin.
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POF1B and POF
POF1B, a gene found only in vertebrates, was discovered
elsewhere to be interrupted by an X;1 balanced transloca-
tion in a patient with secondary amenorrhea.15 Recently,
a mutation analysis study performed on Italian patients
with POF showed that, among several polymorphisms, 1
of 223 patients carried the heterozygous R329Q muta-
tion in the POF1B gene, which was also found in 3 of 900
healthy controls. The authors concluded that there was
no significant association between POF1B and POF.16 The
lack of an association in the Italian study could be due
either to population differences or to the fact that most
of the Italian patients had secondary amenorrhea, whereas
our patients had primary amenorrhea. Therefore, the eti-
ology of each type is likely to be different.
Our data suggest that, in a homozygous state, R329Q is
associated with POF. Since the mother and one daughter,
both unaffected by POF, were heterozygous, and since there
could be consanguinity in this family, a recessive mode
of inheritance is likely. In the control group—women from
the same ethnicity as our familial case—we identified four
heterozygous mutations in 92 individuals. This high fre-
quency of this genotype in Lebanon increases the likeli-
hood of the presence of R329Q at the homozygous state.
Although there is no public health information about the
incidence of POF in the Lebanese population available at
this time, we speculate that there is a relatively high rate
of the condition in that country. Sporadic and familial
cases should be investigated, in a large number of Leba-
nese women, for the presence of R329Q variants.
POF1B Protein Function
Although POF1B is one of the candidate genes for POF, its
function remains unknown. Protein-function predictions
suggest that POF1B shares homology with the myosin tail
portion of the human myosin protein. Also, predictions
support the hypothesis that the presence of the R329Q
mutation affects a phosphorylation site represented by a
triplet of amino acids: serine-leucine-arginine, normally
recognized by the PKC.
Myosin plays an important role in cytokinesis. At the
time of division, filaments of actin and myosin form a
contractile ring, a structure that is fundamental and re-
quired for normal cell division.22–27 Also, it is well known
that phosphorylation events are essential for myosin pro-
tein function. In mammalian smooth muscle and non-
muscle systems, myosin ATPase activity, which regulates
the motor function of the protein, is highly dependent
on phosphorylation events.28 Given the high degree of
homology of POF1B and the myosin tail of the human
myosin protein, we speculate that POF1B is a protein in-
volved in actin-filaments interaction and that the R329Q
variant leads to a lack of phosphorylation at the serine-
leucine-arginine site, which causes the loss of function of
the POF1B protein.
To test the hypothesis that the POF1B mutant binds
actin filaments with less affinity than the wild type, we
assessed the capacity of both wild-type POF1B and the
mutant to bind nonmuscle-actin filaments in vitro. Our
data demonstrated that the variant POF1B binds nonmuscle
actin with less affinity than the wild type, suggesting that
the R329Q variant affects the binding of POF1B with actin.
Molecular Mechanisms of POF1B in POF
Between E16.5 and P5 (during the POF1B expression time
frame), while germ cells within germline cysts enter mei-
osis and progress through the stages of pachytene and
diplotene, massive germ-cell apoptosis occurs.29 In mice,
as in humans, this natural process of female germ-cell loss
occurs to eliminate abnormal cells.30–32 The disruption of
POF1B binding to actin filaments may have various con-
sequences for ovarian-follicle formation. The reported in-
terval of expression of the POF1B mRNA in mouse pre-
cludes its involvement in primordial-germ-cell migration,
since it is first detected at day 16.5 post coitum. Further-
more, at this particular time interval, synaptonemal-com-
plex assembly has occurred, and oocytes are in the pachy-
tene stage. The interval of expression is consistent with a
role of the protein in the transition from pachytene to
diplotene and dictyate arrest. The period from day 16.5 to
birth is characterized by massive germ-cell attrition
through programmed cell death, due to either failure of
completion of meiosis 1 or premature initiation of met-
aphase 1.33 On the basis of the above and the homology
of POF1B to myosin, we speculate that POF1B could play
a role in the pairing of meiotic chromosomes and that
alteration in its function could lead to cell death and a
drastic reduction in the final number of oocytes created
during ovarian development.
Alternatively, POF1B could be involved in the regulation
of germ-cell apoptosis through a role in cytoskeletal dy-
namics. Alterations in the actin cytoskeleton have been
recently implicated in release of reactive oxygen species
from mitochondria and germ-cell apoptosis.34 POF1B may
act as an antiapoptosis factor, to slow down the process
of germ-cell loss. As a consequence, loss of function of
POF1B could lead to exaggerated germ-cell apoptosis and
POF. The precise molecular mechanisms of action of POF1B
in POF will be elucidated by animal models targeting POF1B
in ovarian germ cells.
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